DC potential shifts associated with convulsive seizures and brain monoamine changes in rabbits.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000293:Adolescent; D000818:Animals; D001534:Bemegride / Q000494:pharmacology; D001925:Brain Damage, Chronic / Q000503:physiopathology; D002421:Caudate Nucleus / Q000503:physiopathology; D002540:Cerebral Cortex / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism* / Q000494:pharmacology; D004569:Electroencephalography; D004827:Epilepsy / Q000378:metabolism; D005260:Female; D006185:Habituation, Psychophysiologic; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010775:Photic Stimulation; D011817:Rabbits; D011930:Reaction Time; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology; D012890:Sleep
D012701:Serotonin; D007980:Levodopa; D001534:Bemegride; D006916:5-Hydroxytryptophan; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine